Firm News

Ongoing Pandemic Highlights Importance of S-Signatures

»»Disruption to travel, mail, and in-person meetings caused by the ongoing COVID-19 pandemic has made acquiring signatures problematic and the need for inventor signatures has created a direct impact on the patent procedures for many companies.   To mitigate these issues, it is increasingly important for applicants and their counsel to understand the United States Patent […]

IAM Patent 1000 Recognizes Success of Maier & Maier Firm and Its Partners

»»The 2020 IAM Patent 1000 rankings were announced this week, and Maier & Maier was heavily featured among the highest-level experts in the patent field. Both founding partners Timothy and Christopher Maier were honored, along with renowned partner Stephen Kunin. Per the IAM description honoring the firm, “Christopher Maier and Timothy Maier run a self-titled […]

USPTO Expands COVID Response To Restore Benefit of and Right of Priority to Prior-Filed Applications

»»The USPTO has been active in responding to the COVID-19 pandemic. They’ve extended deadlines for affected applicants and practitioners multiple times, established multiple pilot programs related to the virus, and taken steps to make sure they can continue operations throughout the pandemic. Now the USPTO has expanded its adjustments to allow applicants to restore benefit […]

USPTO Publishes PTAB Rule Changes For Public Comment

»»The USPTO has published proposed changes to the rules governing proceedings at the PTAB. Comments must be submitted by June 26th to be considered. A majority of the changes conform the rules with current PTAB practices already adopted, while one specific change would represent a diversion from the norm. First, the proposal would adopt the […]

USPTO Announces Next Round of Coronavirus Extensions

»»In the past few months, the USPTO has made a number of extensions and changes in response to the spread of coronavirus. Previously, the USPTO had extended deadlines that would have come between March 27 and April 30 by 30 days and then deadlines from March 27 to May 31 to June 1st for those […]

PTAB Discretionary Denial On The Rise

»»The timing considerations that go into filing a petition for inter partes review with the PTAB have become progressively more difficult to navigate as the PTAB exercises increased discretion in rejecting IPRs. This trend started with the precedential NHK decision in which the PTAB rejected an IPR petition on the basis of an upcoming district […]

USPTO Announces Prioritized Examination Pilot Program For COVID-19 Related Applications

»»Continuing its efforts to keep up with COVID-19, the USPTO has announced a prioritized examination pilot program reserved for applications covering products or processes subject to an applicable FDA approval for COVID-19 use. Beginning on July 13, 2020, applicants may request prioritized examination for covered applications. The USPTO’s objective for the pilot is to complete […]

USPTO Launches “Patents 4 Partnerships” Pilot Program

»»In the past few months, the USPTO has made a number of changes in response to the spread of coronavirus. The focus has been both protecting USPTO employees and lessening the burden on affected practitioners and applicants alike. Now the USPTO has begun an effort aimed at solving the problem itself. This month, the USPTO […]

Supreme Court: PTAB’s Institution of IPR Over Time-Bar Unappealable

»»In their decision in Thryv, Inc. v. Click-to-Call Technologies, LP, the Supreme Court ruled that the PTAB’s decisions on 35 U.S.C. § 315(b), the one year time-bar, are final and unappealable. The case began in 2013 at the PTAB with Thryv, Inc. (“Thryv”) and Click-to-Call Technologies, LP (“Click-to-Call”). Thryv filed a petition for an IPR […]

USPTO Extends COVID-19 CARES Act Response Deadlines

»»On March 16, the United States Patent & Trademark Office (“USPTO”) announced that  ‘extraordinary’ circumstances for relief at the USPTO would officially include the effects of COVID-19 “coronavirus”. On March 27, the USPTO announced its further relief response with deadline extensions as authorized by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) executed […]